Bacterial Blood Infections Tied to Heightened Colon Cancer Risk
By LabMedica International staff writers Posted on 12 May 2020 |

Image: Clostridium septicum is a gram positive, spore forming, obligate anaerobic bacterium and increases the risk of colon cancer (Photo courtesy of Alchetron).
Colorectal cancer occurs in the colon or the rectum and it is the third most common type of cancer in the USA. Around 90% of cases occur in people aged 50 years or older. As well as age, risk factors include a family history of colorectal cancer, some genetic syndromes, obesity, and a lack of exercise, a diet low in fruit and vegetables, and inflammatory bowel disease.
Anaerobic bacteria, unlike aerobic bacteria, do not require oxygen in order to function. They are a normal part of the human body, existing in various locations, including the gut. They usually do not cause infections, but when they do, it is most often in the area that the bacteria inhabit. A new study indicates that there is an association between blood infections caused by certain types of bacteria and an increased risk of colon cancer.
A team of scientists associated with Odense University Hospital (Odense, Denmark) gathered data on 45,760 blood infections, including information about the type of pathogens present in the participants’ bloodstreams. Of the 45,760 people who had a bacterial blood infection, 492 (1.1%) later developed colorectal cancer. Of these, 241 (0.5%) were within the first year of the bacterial blood infection. The team matched each of these people by age and sex to a control group of five people who had not had a blood infection.
The investigators reported that compared to people with blood infections caused by aerobic bacteria such as Escherichia coli or Staphylococcus aureus or people without blood infections, those anaerobic bacteria associated with an increased risk of colorectal cancer were: Clostridium septicum (tied to a 42-times increased risk within a year after a blood infection, and a 21-times higher risk overall); and Bacteroides ovatus, (tied to a 13-times increased risk within a year after a blood infection, and a six times higher risk overall).
Ulrik Stenz Justesen, MD, a Clinical Microbiologist and senior author of the study, said, “At this stage we are not sure if the bacteria are directly causing cases of colorectal cancer, or if the blood infection with these bacteria is itself caused by the cancer. It's an example of the question 'is this the chicken or the egg? With regards to screening, if we saw these high risk bacteria in combination with advanced age, then it would definitely be worth screening the person for colorectal cancer.” The study was slated to be presented at the European Congress of Clinical Microbiology and Infectious Diseases which was to be held Apr 18 - 21, 2020 in Paris, France.
Related Links:
Odense University Hospital
Anaerobic bacteria, unlike aerobic bacteria, do not require oxygen in order to function. They are a normal part of the human body, existing in various locations, including the gut. They usually do not cause infections, but when they do, it is most often in the area that the bacteria inhabit. A new study indicates that there is an association between blood infections caused by certain types of bacteria and an increased risk of colon cancer.
A team of scientists associated with Odense University Hospital (Odense, Denmark) gathered data on 45,760 blood infections, including information about the type of pathogens present in the participants’ bloodstreams. Of the 45,760 people who had a bacterial blood infection, 492 (1.1%) later developed colorectal cancer. Of these, 241 (0.5%) were within the first year of the bacterial blood infection. The team matched each of these people by age and sex to a control group of five people who had not had a blood infection.
The investigators reported that compared to people with blood infections caused by aerobic bacteria such as Escherichia coli or Staphylococcus aureus or people without blood infections, those anaerobic bacteria associated with an increased risk of colorectal cancer were: Clostridium septicum (tied to a 42-times increased risk within a year after a blood infection, and a 21-times higher risk overall); and Bacteroides ovatus, (tied to a 13-times increased risk within a year after a blood infection, and a six times higher risk overall).
Ulrik Stenz Justesen, MD, a Clinical Microbiologist and senior author of the study, said, “At this stage we are not sure if the bacteria are directly causing cases of colorectal cancer, or if the blood infection with these bacteria is itself caused by the cancer. It's an example of the question 'is this the chicken or the egg? With regards to screening, if we saw these high risk bacteria in combination with advanced age, then it would definitely be worth screening the person for colorectal cancer.” The study was slated to be presented at the European Congress of Clinical Microbiology and Infectious Diseases which was to be held Apr 18 - 21, 2020 in Paris, France.
Related Links:
Odense University Hospital
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more